181 results on '"Tang, Jinhai"'
Search Results
2. Association between GPRC5A expression and carboplatin efficacy in triple-negative breast cancer patients.
3. Overcoming chemoresistance in triple-negative breast cancer (TNBC): Targeting PD-L1 stability and ferroptosis through integrated lipid metabolism and immune modulation.
4. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER
5. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer
6. Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor–Related Bone Metastases
7. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling
8. RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
9. Accuracy of Thoracic Ultrasonography for the Diagnosis of Pediatric Pneumonia: A Systematic Review and Meta-Analysis
10. Design of Chronic Disease Smart Management and Detection System Based on NB-IoT Technology
11. HJURP indicates poor prognosis of female breast cancer by promoting cell proliferation and migration
12. Systematic review and metanalysis of neutrophil to lymphocyte ratio and prognosis in patients with nasopharyngeal carcinoma
13. The relationship between prognosis and temporal muscle thickness in 102 patients with primary glioblastoma:real-world evidence
14. Reproductive Organ Cancer
15. Advances in the relationship between temporal muscle thickness and prognosis of patients with glioblastoma: a narrative review
16. A simplified non-coplanar volumetric modulated arc therapy for the whole brain radiotherapy with hippocampus avoidance
17. Supplementary Table S2 from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
18. Supplementary Table S2 from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
19. Supplementary Table S1 from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
20. Supplementary Table S1 from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
21. Data from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
22. Supplementary Figure Legend from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
23. Supplementary Figure S1 from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
24. Supplementary Figure S1 from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
25. Supplementary Figure Legend from Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies
26. Abstract P6-14-11: Exosome-mediated Circ-CRSP1 promotes tumor proliferation and metastasis through stabilizing ELAVL1 protein and suppresses anti-tumor immune response in regulating the progression of Triple-Negative Breast Cancer
27. Abstract P4-03-31: Lifestyle factors are associated with breast cancer risk in women biopsied for benign breast diseases in China: 10-year results of a multi-center, hospital-based, case-control study
28. Integrative analysis of the role of BOLA2B in human pan-cancer
29. PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer
30. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
31. Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
32. PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells
33. KCC2 overexpressed exosomes meditated spinal cord injury recovery in mice
34. Mediation role of work motivation and job satisfaction between work-related basic need satisfaction and work engagement among doctors in China: a cross-sectional study
35. Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer
36. Roles and mechanisms of miR-195–5p in human solid cancers
37. A multiple center, open-label, single-arm, phase II clinical trial of MRG002, an HER2-targeted antibody-drug conjugate, in patients with HER2-low expressing advanced or metastatic breast cancer.
38. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
39. Abstract P5-18-06: Proactive diarrhea management improved tolerability of pyrotinib in combination with trastuzumab and docetaxel in patients with HER2+ early or locally advanced breast cancer: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study
40. Abstract PD8-08: Pyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study
41. Abstract P5-18-10: Mecapegfilgrastim for primary prophylaxis of neutropenia in 355 HER2+ breast cancer patients treated with neoadjuvant docetaxel in combination with trastuzumab and/or pyrotinib: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study
42. Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case–Control Study in Chinese Females
43. Hybridized double-shell periodic mesoporous organosilica nanotheranostics for ultrasound imaging guided photothermal therapy
44. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer
45. MGP promotes CD8+ T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer
46. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
47. Elevated expression of LRRC15 Shows Putative Tumor-promoting Characteristics in tumor microenvironment of breast cancer
48. Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
49. Integrated Bioinformatics and Experimental Approaches Identified the Role of NPPA in the Proliferation and the Malignant Behavior of Breast Cancer
50. Effect of statins use on risk and prognosis of breast cancer: a meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.